Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Jasber Kaur Bhogal has worked on the following 10 EPO patent applications which have been published in the last five years:

EP12171016

Production method

IPC classification:
C07K 16/00, C07K 16/18, C12N 15/67, C12P 21/02
Applicant:
Glaxo Group Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
APPLICATION WITHDRAWN
EP12827181

VIRAL CLEARANCE METHODS

IPC classification:
C07K 1/00, C07K 16/00
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12764025

BUFFER SYSTEM FOR PROTEIN PURIFICATION

IPC classification:
C07K 1/18, C07K 1/22, C07K 1/36
Applicant:
GlaxoSmithKline LLC
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12768307

FORMULATIONS WITH REDUCED VISCOSITY

IPC classification:
A61K 39/00, C07K 16/24
Applicant:
GlaxoSmithKline LLC
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13701484

FERMENTATION PROCESS

IPC classification:
A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11726378

HUMANISED ANTIGEN BINDING PROTEINS TO MYOSTATIN6

IPC classification:
A61K 39/395, A61P 21/06, C07K 16/22
Applicant:
Glaxo Group Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13731327

FERMENTATION PROCESS

IPC classification:
C12M 1/00, C12M 1/12, C12M 1/26, C12P 1/04, C12P 21/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14702533

METHOD OF PRODUCING A PROTEIN

IPC classification:
C07K 1/14
Applicant:
Glaxo Group Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14713926

METHODS FOR PURIFYING ANTIBODIES

IPC classification:
B01D 15/20, B01D 15/38, C07K 1/22, C07K 16/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14715423

USE OF TRICARBOXYLIC ACID (TCA) INTERMEDIATES TO CONTROL AMMONIA GENERATION IN CELL CULTURE

IPC classification:
C12N 5/00, C12P 21/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature